Synthetic Hype
By Jonathan Kahn,
Biopolitical Times guest contributor
| 12. 27. 2010
I've been thinking lately about the current excitement over the promise and potential of synthetic biology. The basic idea of synthetic biology is to make biology more like engineering, creating standardized biological "parts" that can be combined to redesign existing biological systems or create entirely new ones that do not already exist in the natural world. It is aptly represented by the concept of "biobricks," a
trademarked term describing "standard biological parts [that] a synthetic biologist or biological engineer can [use to] program living organisms in the same way a computer scientist can program a computer."
I am concerned because this seems to be the latest in a long line of grand promises that have accompanied demands for resources (both monetary and intellectual) for successive major biotechnological undertakings over the past twenty years. Each of these undertakings has been worthy in its own right but none has, as yet, come anywhere near to realizing the extravagant claims made by its initial promoters. Modern developments in biotechnology have been driven, in part, by an ever receding horizon of promise. Many scholars...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Emile Torres, Jacobin | 11.15.2025
Watching tech moguls throw caution to the wind in the AI arms race or equivocate on whether humanity ought to continue, it’s natural to wonder whether they care about human lives.
The earnest, in-depth answer to this question is just...